PTGS2 and cardiovascular disorder: As elevated uric acid levels are also known to be an independent risk factor for cardiovascular diseases [44], alterations of melatonin secretion may represent a possible link: a study by Mayo et al. indicated that melatonin is able to lower systemic inflammation caused by elevated uric acids levels via inhibition of cyclooxygenase 2, which may reduce mitochondrial dysfunction [45].